NIPPON INDIA CONSERVATI…₹3.84▲237.03% NIPPON INDIA EQUITY SAV…₹0.65▲126.00% NIPPON INDIA TAIWAN EQU…₹33.87▼2.96% INVESCO INDIA GOLD ETF₹42.68▲2.72% NIPPON INDIA NIFTY REAL…₹8.42▲2.57% TATA NIFTY REALTY INDEX₹9.27▲2.57% QUANTUM GOLD ETF₹57.72▲2.54% UNION GOLD ETF₹17.38▲2.48% AXIS GOLD₹44.11▲2.42% BANDHAN GOLD ETF₹9.97▲2.34% NIPPON INDIA CONSERVATI…₹3.84▲237.03% NIPPON INDIA EQUITY SAV…₹0.65▲126.00% NIPPON INDIA TAIWAN EQU…₹33.87▼2.96% INVESCO INDIA GOLD ETF₹42.68▲2.72% NIPPON INDIA NIFTY REAL…₹8.42▲2.57% TATA NIFTY REALTY INDEX₹9.27▲2.57% QUANTUM GOLD ETF₹57.72▲2.54% UNION GOLD ETF₹17.38▲2.48% AXIS GOLD₹44.11▲2.42% BANDHAN GOLD ETF₹9.97▲2.34%
GFS GFSGayatri Financial Synergy
/
Client Login
GFS » Mutual Fund » Sectoral / Thematic » UTI Healthcare Fund
Published NAVNAV published by the AMC, sourced from AMFI
-2.99119.42241.83364.253 Apr 20063 Sep 2026
Change+1317.5%change over the window — not annualised
Low / high₹16.68 / ₹344.573 Mar 2009 · 31 Aug 2026
Last print+0.45%2 Sep 2026 → 3 Sep 2026
Prints5,024published NAVs, AMFI · axis does not start at zero

Returns

NAV and returns as at 03 Sept 2026
Lumpsum · point to point
1W +0.52%
1M +2.23%
3M +12.57%
6M +22.39%
YTD +20.89%
1Y +17.89%
2Y CAGR +10.66%
3Y CAGR +24.07%
5Y CAGR +15.09%
10Y CAGR +13.82%
SIP · XIRR on monthly instalments
6M SIP +56.43%
1Y SIP +32.77%
2Y SIP +18.75%
3Y SIP +20.1%
5Y SIP +21.26%
10Y SIP +18.69%
Full history SIP +15.84%
Periods up to one year are absolute; longer periods are annualised (CAGR). SIP figures are the XIRR of a fixed monthly instalment over the same window. — means this scheme’s NAV history does not cover that period — across all 1648 schemes, 68.3% have a 3-year figure, 49% a 5-year one, and 32.2% a 10-year one.

Returns vs category

1Y
This fund
+17.89%
Sectoral / Thematic avg
+7.67%
3Y
This fund
+24.07%
Sectoral / Thematic avg
+14.39%
5Y
This fund
+15.09%
Sectoral / Thematic avg
+12.3%
Average is the mean of every Sectoral/ Thematic scheme in this dataset that discloses the period — 218 schemes at 1Y, 128 at 3Y, 94 at 5Y. Returns beyond one year are annualised.

Top holdings

as at 31 Jul 2026 · source: AMC monthly portfolio disclosure
EQ - SUN PHARMACEUTICALS INDUSTRIESPharmaceuticals & Biotechnology 8.71%
EQ - DIVIS LABORATORIES LTD.Pharmaceuticals & Biotechnology 5.57%
EQ - AJANTA PHARMA LTD.Pharmaceuticals & Biotechnology 4.8%
EQ - CAPLIN POINT LABORATORIES LTDPharmaceuticals & Biotechnology 3.95%
EQ - LUPIN LTD.Pharmaceuticals & Biotechnology 3.59%
EQ - GLAND PHARMA LTD.Pharmaceuticals & Biotechnology 3.56%
EQ - APOLLO HOSPITALS ENTERPRISE LTHealthcare Services 3.46%
EQ - DR REDDYS LABORATORIES LTD.Pharmaceuticals & Biotechnology 3.1%
EQ - ALKEM LABORATORIES LTDPharmaceuticals & Biotechnology 3.1%
EQ- GLOBAL HEALTH LTD.Healthcare Services 2.81%
Top 10 42.65%Securities 44Securities total 97.06%Cash & equivalents 2.92%
The ten largest securities by weight, out of 44 disclosed. Weight is percent of net assets as filed. Cash-equivalent lines (TREPS, reverse repo, net receivables, margin) and derivative legs are counted in the chips above but not ranked among securities, because a short futures leg is filed as a negative weight and sorting it alongside a shareholding describes no portfolio. A portfolio is a point-in-time filing and changes every month.

Risk

Volatility · annualised · 3Y
14.74%
Max drawdown · 3Y
-16.02%
Sharpe ratio
1.15
SEBI riskometer
Very High
Volatility is the annualised standard deviation of daily NAV moves over the last three years; max drawdown is the deepest peak-to-trough fall in that same window. Where a scheme has less than three years of NAV, the window is what it actually has and is labelled as such — never as three years. Sharpe is as disclosed in the scheme key-ratio feed (as at 24 July 2026).
Beta and alpha are not shown. No benchmark series in the source.

Cost

Expense ratio1.28%
Category average1.73%
Exit load1%
52W high / low₹344.5735 / ₹268.5857
Expense ratio 1.28% vs a category average of 1.73% — 0.45 percentage points lower. Among Sectoral/ Thematic schemes disclosing an expense ratio it is 110th of 166, cheapest first.
Expense ratio and category average are as disclosed against this scheme in the source; 78.5% of schemes here carry one. The ratio is charged inside the NAV, so every return on this page is already net of it.

Scheme facts

SEBI sub-category Sectoral/ Thematic
Plan / option Regular Growth
Benchmark BSE Health Care - TRI
Fund manager Kamal Gada
Launched 27 May 1999
NAV history here 10.0y
ISIN INF789F01TO9
AMFI scheme code 100807
SEBI riskometer Very High
Exit load 1%
Lock-in None
Minimum lumpsum ₹5,000
Exit load, as disclosed: 1% on or before 30D · Nil after 30D
Not shown on this page, and why
Star rating — GFS is an AMFI-registered distributor (ARN-169480), not a SEBI-registered investment adviser. It does not rate schemes.
Scheme AUM — Scheme-level AUM is not in the source; only AMC-total AUM, which is a different number.
Minimum SIP — Not present in the source.
Beta and alpha — No benchmark series in the source.

General SIP calculator

A general SIP illustration: your monthly amount grown at the annual rate you set below, compounded monthly. The rate is your assumption — it is not this scheme’s past return, not a forecast of it, and mutual fund returns are not assured.
Monthly SIP₹10,000
Tenure10 years
Assumed annual return12%
Invested₹12,00,000
Est. gain₹11,23,391
Total value₹23,23,391